Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Common Equity: 2020-2024

Historic Common Equity for Agilon Health (AGL) over the last 5 years, with FY2024 value amounting to $471.0 million.

  • Agilon Health's Common Equity fell 4675.74% to $306.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $306.1 million, marking a year-over-year decrease of 4675.74%. This contributed to the annual value of $471.0 million for FY2024, which is 2884.19% down from last year.
  • According to the latest figures from FY2024, Agilon Health's Common Equity is $471.0 million, which was down 2884.19% from $661.8 million recorded in FY2023.
  • Agilon Health's 5-year Common Equity high stood at $1.1 billion for FY2021, and its period low was -$284.7 million during FY2020.
  • Moreover, its 5-year median value for Common Equity was $661.8 million (2023), whereas its average is $596.2 million.
  • Per our database at Business Quant, Agilon Health's Common Equity surged by 48348.47% in 2021 and then tumbled by 3643.62% in 2023.
  • Agilon Health's Common Equity (Annual) stood at -$284.7 million in 2020, then skyrocketed by 483.48% to $1.1 billion in 2021, then fell by 4.64% to $1.0 billion in 2022, then tumbled by 36.44% to $661.8 million in 2023, then decreased by 28.84% to $471.0 million in 2024.
  • Its last three reported values are $471.0 million in FY2024, $661.8 million for FY2023, and $1.0 billion during FY2022.